Utah Becomes First State to Allow AI Prescriptions for Acne Treatment Without Direct Doctor Oversight

12 Sources

Share

Utah launched a groundbreaking pilot program allowing AI to examine patients and prescribe acne medication autonomously. Nolla Health's app uses facial scans to generate acne severity scores and issue prescriptions for mild-to-moderate cases at $4.99/month, with gradually reducing physician oversight over three phases.

Utah Breaks New Ground with AI-Powered Medical Prescriptions

Utah has become the first U.S. state to authorize AI prescriptions for initial medication, marking a significant shift in how AI in healthcare operates. Healthcare startup Nolla Health launched its Nolla Derm app on Monday, enabling residents to receive AI-generated acne prescriptions without direct human oversight

1

2

. The service costs $4.99 per month and targets adults 18 years and older with mild-to-moderate acne

2

3

. This Utah pilot program differs from previous AI healthcare initiatives by allowing the system to issue initial prescriptions rather than just renewals, positioning it as a first-of-its-kind experiment in autonomous medical decision-making.

Source: Inc.

Source: Inc.

How the AI-Only Examination and Prescription Process Works

Patients use the Nolla Derm app to complete a facial scan and submit their medical history through digital forms. The AI-powered service analyzes the images to assess skin oiliness and generate an acne severity score ranging from clear skin to severe acne

4

. By combining this score with the patient's medical information, the system selects from eight approved topical treatments and issues a prescription within 10-15 minutes

3

. Cases involving severe acne, pregnancy, or other complicating factors are automatically referred to licensed physicians rather than receiving AI examine patients and prescribe medication autonomously

3

.

Source: Interesting Engineering

Source: Interesting Engineering

Phased Approach to Physician Review and Human Oversight

The one-year pilot implements a three-stage rollout with progressively reduced human oversight. During the first phase, two board-certified physicians will independently review and approve every AI-generated acne prescription before it reaches pharmacies for the initial 100 patients

1

4

. The second phase expands to 400 patients, with physician review occurring retrospectively at least weekly after prescriptions are already sent to pharmacies

1

4

. In the final phase, physicians audit only 10% of prescriptions monthly, plus any cases involving escalations or side effects

2

3

.

Regulatory Approval and Medical Community Response

Nolla Health secured regulatory approval through Utah's Office of AI Policy, part of the Department of Commerce tasked with guiding responsible AI policies

1

. The Utah Medical Association was not directly involved in approving the program, though the Office of AI Policy consulted with the association's president, a dermatologist, and the Utah Medical Licensing Board subcommittee

1

. Michelle McOmber, CEO of the Utah Medical Association, characterized this as a "very limited and very specific" use case acceptable for AI but emphasized the organization "would not be in favor of it being used for anything else at this time"

1

. McOmber stressed that "care decisions ultimately should rest with the physician in consultation with the patient" and warned that "AI, if used inappropriately, can be very dangerous in healthcare"

1

.

Addressing Healthcare Access Gaps in Utah

The program responds to significant dermatology access challenges in Utah. The average wait for a dermatology appointment in the state is 61 days, nearly double the national median, and 11 counties have no dermatologist at all

3

. Visits can cost up to $300, creating barriers for patients with mild-to-moderate acne who may develop permanent scarring while waiting for treatment

3

. Nolla Health positions its service as complementing rather than replacing physicians, stating it aims to handle routine, low-acuity cases so dermatologists can focus on complex, high-risk patients

2

.

Source: PC Magazine

Source: PC Magazine

Future Expansion Plans and Broader Implications

Dr. Zaid Fadul, Nolla Health's Chief Medical Advisor, indicated the healthcare startup is exploring expansion into other conditions if the acne medication trial succeeds, including rosacea, flu, and UTIs with limited complications

3

5

. The company is also developing medical wearables, heart monitoring, bloodwork analysis, female hormone and cycle tracking, and menopause treatments

3

. Fadul emphasized that the AI "can't improvise" and is limited to a "short list of physician-approved topical treatments" with adverse effects restricted to localized skin irritation or dryness

5

4

. Utah is simultaneously running four other AI healthcare pilots through the Office of AI Policy, including programs for postpartum physical therapy, routine prescription refills, and psychiatric medication

3

5

. This represents a broader state-level experiment in determining which healthcare functions AI can safely automate and where human judgment remains essential.

Today's Top Stories

© 2026 TheOutpost.AI All rights reserved